The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

Table of Contents

Chapter One: Executive Summary

• Scope and Methodology
• Size and Growth of the Market
• Market Trends

Chapter Two: Introduction

• Lab Medicine Disciplines and Applications
• Market Analysis of IVD Market Segments
• Market Events
• Top Suppliers and Niche Players
• Point of View

Chapter Three: Overview of Global In Vitro Diagnostic Markets

• The Global Community Strives for Regulatory Harmonization
• World Segments of the IVD Market and IVD Market Evolution
  • The United States—A Free Market in Disguise
  • Japan—Holding Its Own
  • Europe—Economic Crisis Drives Reorganization
  • China—The WTO Powerhouse
  • The Lure of Emerging Markets
    • India
    • Latin America
    • East Asia
• IVD Market Growth— Segments and Technologies
  • Traditional IVDs
  • Emerging Tests and Technologies
    • Protein Patterns
    • New Immunoassay Technology
    • New Molecular and Miniaturization Tests and Devices

Chapter Four: Trends in Healthcare Delivery and In Vitro Diagnostics

• Miniaturization and Chip Progress
• Non-Invasive Techniques and Alternative Samples
• Commercialization Issues: Patents and Market Innovation
• Direct to Consumer Marketing
• Patient Management and Outcomes-Based Medicine
• Economics of New Tests and Technologies— The Old Don’t Disappear
• Post Genomics and Pharmacogenomics— Reality Check
• Regulatory and Reimbursement Issues and Novel Devices

Chapter Five: Point-of-Care Tests

• Overview
• POC Test Segments
  • Patient Self Tests
  • Professional POC
  • Market Analysis: Leading Suppliers
• Self-Testing Segments
  • Blood Glucose
  • Pregnancy/Ovulation
  • Coagulation/PT
  • Fecal Occult Blood
  • Cholesterol
• Professional Testing Segments
  • Critical Care
  • Cholesterol
  • Coagulation
  • Cardiac Markers
  • Infectious Diseases
  • Cancer Markers
• Institutional Users of POC Tests
• The Commercial Outlook for POC Tests

Chapter Six: Clinical Chemistry

• Overview of Chemistry Tests
• Market Analysis: Leading Suppliers and Growth Potential
  • Suppliers
  • Geographic Markets
  • Segments
    • General Chemistry
    • Blood Gases
    • Urinalysis
• Lab Automation and Work Station Consolidation
• The Commercial Outlook for Chemistry Tests

Chapter Seven: Immunoassays

• Overview of Immunoassays
• Market Analysis: Leading Suppliers and Growth Potential
• Immunoassay Test Segments— Mature, Maturing and Emerging
  • Thyroid Function
  • Therapeutic drug tests
  • Anemia
  • Fertility
  • Tox/DAU
  • Allergy
  • Infectious Diseases
  • Proteins
  • Tumor Markers
  • Cardiac Markers
  • Autoimmune
  • Sepsis
  • Miscellaneous
• Proteins in Post Genomic Medicine
• The Commercial Outlook for Immunoassays

Chapter Eight: Molecular Assays

• Overview
• Market Analysis: Leading Suppliers and Growth Potential
  • Infectious Diseases
  • SNPs, Inherited Diseases, Oncology
    • Thrombophilia—Factor V Leiden, Factor II Prothrombin, MTHFR
    • Cystic Fibrosis
    • Hemochromatosis
    • Gene Methylation
    • Circulating Cell-free Nucleic Acids
    • Ribonucleic Acid (RNA)
  • Prenatal Screening
  • Tissue Typing
• Molecular Testing Initiatives: Technology and Players
• Post Genomic Medicine and the Gene/Protein Mix
• PCR Patents and Innovation
• The Commercial Outlook for Molecular Tests

Chapter Nine: Hematology

• Overview
• Market Analysis: Leading Suppliers and Growth Potential
• Decentralized Hematology Testing
• The Commercial Outlook for Hematology Tests

Chapter Ten: Coagulation

• Overview of Coagulation and Immunohematology Tests
• Market Analysis: Leading Suppliers and Growth Potential
  • Lab-Based Coag
  • Hospital POC
  • Coagulation Self-Testing
• The Commercial Market for Coagulation Tests

Chapter Eleven: Microbiology and Virology

• Overview
• Market Analysis: Leading Suppliers and Growth Potential
  • Supplies
  • Organism Identification and Antimicrobial Resistance Testing (ID/MIC)
  • Blood Culture
  • Rapid Tests
• Antimicrobial Resistance—A Moving Target
• Tradition Is Challenged by Molecular Techniques
• Emerging Organisms and the Globalization of Infectious Diseases—West Nile, SARS, and Influenza
• The Commercial Outlook for Microbiology / Virology Tests

Chapter Twelve: Blood Banking Services

• Overview
• World Blood Banking Developments
• Market Analysis: Leading Suppliers and Growth Potential
  • Blood Grouping
  • Immunoassays
  • Nucleic Acid Testing (NAT) Continues to Grow
• Artificial Blood Products Begin to Appear
• The Commercial Outlook for Blood Banking

Chapter Thirteen: Histology and Cytology

• Overview
• Market Analysis: Leading Suppliers and Growth Potential
  • Traditional Stains
  • Immunohistochemical Stains (IHC) and In Situ Hybridization (ISH)
  • Tissue Microarrays
  • Circulating Tumor Cells
• Genomic Medicine Fuels Histology Pharmacogenomics
• Flow Cytometry on the FLOW
• The Commercial Outlook for Histology and Cytology Tests

Chapter Fourteen: Company Profiles: The Top Tier

• Abbott Labs
• ARKRAY (formerly Kyoto Daiichi)
• Bayer Corporation, Diagnostics Division
• Becton, Dickinson and Company (BD)
• Beckman Coulter Inc.
• bioMerieux Inc.
• Bio-Rad Laboratories Inc.
• Chiron Corporation
• Cytyc Corporation
• Dade Behring Inc.
• Dako A/S
• Diagnostic Product Corporation (DPC)
• Gen-Probe Incorporated
• Instrumentation Laboratory (IL)
• Inverness Medical Innovations, Inc.
• LifeScan Inc.
• Nova Biomedical
• Olympus America Inc.
• Ortho Clinical Diagnostics (OCD)
• Qiagen N.V.
• Radiometer A/S
• Roche Diagnostics
• Sysmex Corporation
• Ventana Medical Systems

Chapter Fifteen: Company Profiles: The Second Tier

• ABAXIS Inc.
• Accumetrics Incorporated
• AcroMetrix Corporation
• Adeza Biomedical, Inc.
• AESKU.Diagnostics GmbH
• Affymetrix Inc.
• Applied Imaging Corp.
• Ambion Diagnostics
• Applied Biosystems Group
• Arcturus Bioscience Inc.
• artus GmbH
• Axis-Shield plc
• Binding Site Inc. (The)
• Biosite Incorporated
• Boule Diagnostics International AB
• B·R·A·H·M·S Aktiengesellschaft
• Caliper Life Sciences, Inc.
• Celera Diagnostics
• Cepheid
• Chempaq A/S
• Cholestech Corporation
• Ciphergen Biosystems, Inc.
• Clarient (formerly ChromaVision Medical Systems, Inc.)
• Clinical Data, Inc. (formerly Novitron International, Inc.)
• Diagnostica Stago
• DiaSorin S.p.A.
• Digene Corporation
• Eiken Chemical Co., Ltd.
• Fujirebio Diagnostics Inc.
• Genzyme Corporation
• Greiner Bio-One International AG
• Hardy Diagnostics
• HemoCue AB
• HemoSense , Inc.
• Hemosystem SA
• Hitachi High-Technologies Corporation.
• Home Diagnostics, Inc.
• Horiba ABX S.A.
• Hypoguard, USA Inc.
• Idaho Technology, Inc.
• Illumina
• Immucor Inc.
• Immunicon Corporation
• Innogenetics
• International Technidyne Corp (ITC)
• Invitrogen Corporation
• IRIS International, Inc.
• i-Stat
• KREATECH Biotechnology B.V.
• Laboratory Corporation of America Holdings (LabCorp)
• Luminex Corporation
• Matritech
• Mayo Medical Laboratories
• Medtronic Diabetes
• Meridian Bioscience, Inc.
• Metrika Inc.
• Micronics, Inc.
• Monogram Biosciences, Inc. (formerly Virologic, Inc.)
• Nanogen Inc.
• OraSure Technologies, Inc.
• Osmetech plc
• Oxford Immunotec Limited
• Oxoid Limited
• Pall Corporation
• Panbio Limited
• Partec GmbH
• PerkinElmer, Inc.
• Phadia AB (formerly Pharmacia Diagnsotics AB)
• Polymedco, Inc.
• Quest Diagnostics Inc.
• Quidel Corporation
• Randox Laboratories Ltd.
• Remel, Inc.
• Sakura Finetek USA Inc.
• Sequenom Inc.
• SIRS-Lab GmbH
• Specialty Laboratories/Ameriparth, Inc.
• Stratagene Corporation / Hycor Biomedical Inc.
• TheraSense, Inc.
• Third Wave Technologies, Inc.
• Tm Bioscience Corp.
• TOSOH Corporation
• Trinity Biotech plc
• TriPath Imaging, Inc.
• Wako Pure Chemical Industries, Ltd.

Chapter Sixteen: Company Profiles: The Third Tier

• 454 Life Sciences
• ABTECH Scientific, Inc.
• Accelr8 Technology Corp.
• Acolyte Biomedica Ltd
• Acrongenomics Inc.
• Adaltis Inc.
• ADIATEC
• Addison-Davis Diagnostics, Inc. (ADDI)
• Adlyfe, Inc.
• AdnaGen AG
• Advalytix AG
• Advanced Biological Laboratories SA (ABL)
• Advance Nanotech, Inc.
• Advanced Analytical Technologies Inc.
• AdvanDx, Inc.
• Aerocine AB
• Agencourt Bioscience Corporation
• Agendia B.V.
• Akers Biosciences, Inc.
• Alpco Diagnostics
• Alopex GmbH
• Ambry Genetics
• AMDL, Inc.
• American Bio Medica Corporation
• American Diagnostica Inc. (ADI)
• Amnis Corporation
• Animas Corporation
• ANP Technologies, Inc.
• Aphton Corporation
• Applied NeuroSolutions, Inc.
• Ark Therapeutics Limited
• Assay Designs, Inc.
• Associates of Cape Cod, Inc.
• Attogenix Biosystems Pte Ltd
• AusAm Biotechnologies, Inc.
• AutoGenomics, Inc.
• Avitar, Inc.
• AVIVA Biosciences
• Bacterial Barcodes Inc.
• Banyan Biomarkers
• Baxter Healthcare Corporation
• bcs BIOTECH S.p.A.
• Bedfont Scientific Ltd
• Bender MedSystems GmbH
• BioArray Solutions, Ltd.
• Biocept, Inc.
• BioCurex, Inc.
• BioGenex Laboratories
• Biohit Plc.
• Bio-Layer Corporation Ltd.
• Biolog Inc.
• bioLytical Laboratories Inc.
• Biomarker Technologies LLC
• Biomedical Diagnostics, LLC
• Biomerica Inc.
• Biomoda Inc.
• Bionomics Limited
• Biophage Pharma Inc.
• Biophysical Corporation
• BioPredictive S.A.S
• Biosafe Medical Technologies, Inc.
• Biotools, B & M Labs, S.A.
• BioVeris Corporation
• BIOVIEW, Inc.
• BioVisioN AG
• Bmd, Biomedical Diagnostics
• Boditech Med Inc.
• Bruker Biosciences Corporation
• CCC Diagnostics LLC
• Calypte Biomedical Corporation
• Cancer Genetics Inc.
• Cangen Biotechnologies, Inc.
• Celerus Diagnostics
• CellaVision AB
• Cellestis Ltd.
• CeMines, Inc.
• Chembio Diagnostics, Inc.
• ChemGenex Pharmaceuticals Limited
• Chemicon International, Inc.
• ChemSensing, Inc.
• China Medical Technologies, Inc.
• ChondroGene Limited
• Cis Biotech, Inc.
• CLONDIAG chip technologies GmbH
• co.don Tissue Engineering, Inc.
• CombiMatrix Corporation
• Competitive Technologies, Inc.
• CompuCyte
• Corgenix Medical Corporation
• Correlagen Diagnostics, Inc.
• Correlogic Systems, Inc.
• Cortex Biochem Inc.
• C.S.F. srl
• Cygnus Inc.
• Cylex Incorporated
• CytoCore Inc. (formerly Molecular Diagnostics, Inc.)
• Daiichi Pure Chemicals Co., Ltd.
• DexCom Inc.
• Diabetech, LP
• Diabetes Sentry Products Inc.
• diaDexus, Inc.
• DiagnoCure Inc.
• Diagnostic Chemicals Ltd (DCL)
• Diagnostic Systems Laboratories Inc. (DSL)
• Diaglobal GmbH
• Diamedix Corporation/Ivax Diagnostics
• DiaSys Corporation
• Diazyme Laboratories
• Digital Bio Technology/ InCyto
• DMetrix, Inc.
• DNA Bioscience
• DNA Direct, Inc.
• DNAPrint genomics, Inc.
• DxS Ltd.
• Dynal Biotech ASA
• Dynex Technologies
• eGene Inc.
• Enzo Biochem, Inc.
• Epigenomics AG
• Epitome Biosystems
• Epoch Biosciences, Inc.
• Equal Diagnostics
• EraGen Biosciences Inc.
• EXACT Sciences Corporation
• Exagen Diagnostics, Inc.
• Exiqon A/S
• FALCO biosystems Ltd.
• Focus Diagnostics, Inc. (formerly Focus Technologies)
• Fujifilm Diagnostics (Fujifilm GmbH)
• GEN ID Lab Services Inc.
• Genaco Biomedical Products, Inc.
• Genaissance Pharmaceuticals, Inc.
• GenBio
• Genekam Biotechnology AG
• Genelex Corporation
• GeneOhm Sciences, Inc.
• Generex Biotechnology Corporation
• GenoID Ltd.
• GenoMed, Inc.
• Genomic Health, Inc.
• Genomic Profiling Systems (GPS)
• Genoptix Inc.
• GENPOINT AS
• Gentra Systems Inc.
• Gentris Corporation
• Geron Corporation
• Global Detection & Reporting, Inc. (GDR)
• GlucoLight Corporation
• Glucon Medical Ltd
• Glycominds Ltd.
• Grant Life Sciences Inc.
• Grifols S.A.
• Guava Technologies, Inc.
• GW Medical Technologies LLC
• Gyros AB
• Hamilton Thorne Biosciences, Inc.
• HealthCheckUSA
• Healthy Estrogen.com, Inc.
• Hema Diagnostic Systems, LLC
• HistoRx, Inc.
• IBEX Technologies Inc.
• Ibis Technologies
• IBL-America
• Identa Corporation
• Ikonisys, Inc.
• Innotrac Diagnostics Oy
• Innovative Biosensors, Inc. (IBI)
• Insulet Corporation
• InterGenetics Incorporated
• IntraCellular Diagnostics, Inc.
• Invirion Inc.
• IPGDx
• Ipsogen
• Integrated Nano-Technologies, LLC (INT)
• Integrated Sensing Systems, Inc. (ISSYS)
• IntegraGen SA
• IQuum Inc.
• Isotechnika Inc.
• amiya Biomedical Co.
• KineMed, Inc.
• Knopp NeuroSciences Inc.
• KRONUS Inc.
• LGM International Inc
• LifeSpan BioSciences
• Lifestream Technologies
• LightUp Technologies AB
• LipoScience, Inc.
• Luminous Medical Inc.
• MacoPharma SA
• Magellan Biosciences
• MAST GROUP Ltd.
• MedCap Corp.
• Medical Services International Inc.
• Medical Wire & Equipment Co. (MW&E)
• MedMira Inc.
• Medicorp Inc.
• MelTec GmbH & Co. KG
• A. Menarini Diagnostics
• Menssana Research
• Metabolon, Inc.
• MetriGenix Corporation
• MicroFluidic Systems Inc. (MFSI)
• Milenia Biotec GmbH
• Milestone Medical
• Millipore Corporation
• Miraculins Inc.
• J. Mitra & Co. Pvt. Ltd.
• Mobidiag Oy
• Mobious Genomics Ltd.
• Molecular Probes
• Molzym GmbH & Co.
• Monogen, Inc.
• Mossman Associates, Inc.
• Nanobac Life Sciences, Inc.
• NanoLogix, Inc. (formerly Infectech Inc.)
• Nanosphere Inc.
• The National Center for Genome Resources (NCGR)
• N-Dia, Inc.
• NetImpact Holdings, Inc.
• NIR Diagnostics Inc.
• NTD Laboratories
• Nymox Pharmaceutical Corporation
• OncoMethylome Sciences S.A.
• One Cell Systems, Inc.
• Orchid Biosciences, Inc.
• ORGENTEC Diagnostika GmbH
• Orion Genomics
• Orpegen Pharma
• Oxford Biosensors Ltd.
• OXIS International Inc.
• Oxonica plc
• ParAllele Bioscience, Inc.
• PathWork Informatics Inc.
• Pelikan Technologies Inc.
• Perceptronix Medical Inc.
• Pharmanetics, Inc.
• Philips Medical Systems
• Phoenix Bio-Tech Corp
• PlaCor, Inc.
• PointCare Technologies, Inc.
• Polymer Technology Systems, Inc.
• PortaScience, Inc.
• Power3 Medical Products, Inc.
• PreAnalytiX GmbH
• PrecisionMed Inc.
• Predicant Biosciences Inc. (formerly Biospect Inc.)
• Predictive Diagnostics, Inc.
• PreMD Inc. (formerly IMI International Medical Innovations, Inc.)
• Primagen Holding B.V.
• Princeton BioMeditech Corporation
• Prodesse Inc.
• Progenika Biopharma, S.A.
• PrognostiX Inc.
• Pro-Lab Diagnostics
• Proteome Systems Ltd
• Provalis Diagnostics
• pSivida Limited
• QuantomiX Ltd.
• Raman Systems Inc. (RSI)
• Relative Genetics
• Rennesens GmbH
• Renovar, Inc.
• Repromedix Corp.
• Response Biomedical Corp.
• Rubicon Genomics, Inc.
• Saliva Diagnostic Systems , Inc. (SDS)
• ScheBo-Biotech AG
• Schleicher & Schuell BioScience, Inc.
• Sciperio Inc.
• Sepal Reproductive Devices
• Separation Technology Inc.
• Sequella Incorporated
• Seryx LLC
• Shenzhen PG Biotech Co Ltd (PG Biotech)
• Siemens AG
• Signet Laboratories Inc. 1
• Silex Microsystems
• Smiths Medical MD, Inc. (formerly Deltec, Inc.)
• SomaLogic, Inc.
• Sontra Medical Corporation
• Source MDx
• Spectral Diagnostics Inc.
• Sphere Medical Ltd.
• STMicroelectronics
• Suracell Inc.
• SureScreen Diagnostics, Ltd.
• Synova Healthcare, Inc.
• Takara Bio Inc.
• Targeted Diagnostics & Therapeutics, Inc. (TDT)
• TECHLAB Inc.
• Tessera Diagnostics
• Theranostech, Incorporated
• ThyroTec, Inc.
• TREK Diagnostic Systems, Inc.
• Trillium Diagnostics, LLC
• United Biotech, Inc. (UBI)
• U.S. Genomics
• Veredus Laboratories Pte
• Veridex LLC
• VIRCO BVBA
• Vision BioSystems Ltd.
• Vita Genomics
• WaveSense LLC
• WayPoint Biomedical, Inc.
• Whatman Inc.
• Xact Aid, Inc.
• XDx Inc.
• Xenomics, Inc.
• York Nutritional Laboratories
• Zila, Inc.
• Zonda, Inc.
• Zymed Laboratories Inc.
• ZymeQuest, Inc.

List of Exhibits

Chapter One: Executive Summary

• Table 1-1 Exchange Rate Fluctuations, 2000-2005
• Table 1-2 Worldwide In Vitro Diagnostic Reagent Sales by Country/Region 2005-2010

Chapter Two: Introduction

• Table 2-1 Worldwide In Vitro Diagnostic Sales by Product Segment (Clinical Chemistry, Immunoassays [Infectious Disease, Blood Bank Screening, and Other], Hematology, Microbiology, Radioimmunoassays, Coagulation, Histology/Cytology, Nucleic Acid Assays, Blood Grouping/Typing, Flow Cytometry, POC [OTC Diabetes, OTC Other, Professional]) 2005-2010
• Table 2-2 20 Years in the World IVD Market Performance of Selected Markets and Products by Type (Chemistry, Immunoassays, Hematology, Microbiology, Coagulation, Histology/Cytology, Molecular, Diabetes, POC Professional, Blood Group/Type, Flow Cytometry; Cardiac Markers, Tumor Markers, Autoimmune Assays) 1990 to 2010
• Table 2-3 Major Diagnostics Industry Acquisitions 2005
• Table 2-4 Major Diagnostics Industry Distribution Agreements 2005
• Table 2-5 Revenues of Top IVD Companies (30 Companies), 2001-2005

Chapter Three: Overview of Global In Vitro Diagnostic Markets

• Table 3-1 Old-Age Dependency Ratios (Eldery as a Percentage of Working-Age Population) Comparative Projections by Country 2000 vs 2025
• Table 3-2 Worldwide In Vitro Diagnostic Reagent Sales by Country/Region 2005-2010
• Table 3-3 European Union IVD Sales by Country 2005 vs 2010
• Table 3-4 Estimated IVD Market Growth Rates of Selected European Countries (13 Countries)
• Table 3-5 Number of Medical Institutions in China by Type
• Table 3-6 Selected IVD Companies Involved in International Marketing Efforts
• Table 3-7 Worldwide In Vitro Diagnostic Reagent Sales by Product Market 2005-2010

Chapter Four: Trends in Healthcare Delivery and In Vitro Diagnostics

• Table 4-1 Selected New Biochip/Array Products 2005
• Table 4-2 Selected IVD Manufacturer Collaborations and License Agreements, 2005
• Table 4-3 Selected IVD Patents Litigations, 2005
• Table 4-4 Selected Direct to Consumer Tests
• Table 4-5 Selected OTC Tests, 2005
• Table 4-6 Selected States That Allow Direct-to-Consumer Lab Testing

Chapter Five: Point-of-Care Tests

• Table 5-1 Selected Diabetes Management Programs
• Table 5-2 Selected OTC Test Devices, 2005
• Table 5-3 Selected Professional POC Tests on the Market and in Development, 2005
• Table 5-4 POC Test Sales by Test Category 2005-2010
• Table 5-5 Selected Diabetes Test Devices Commercialized 2005
• Table 5-6 Selected Diabetes Test Devices in Development, 2005

Chapter Six: Clinical Chemistry

• Table 6-1 Clinical Chemistry/Immunoassay Sales by Type (General Chemistries, Immunoassays on Workstations, Immunoassays on Immunoanalyzers) 2005-2010
• Table 6-2 Chemistry/Immunochemistry Sales of Top Five Manufacturers, 2003-2005
• Table 6-3 Worldwide Clinical Chemistry Sales by Test Category 2005-2010
• Table 6-4 Selected Innovations in Clinical Chemistry, 2005

Chapter Seven: Immunoassays

• Table 7-1 Summary of Immunoassay Developments, 2002-2005
• Table 7-2 Worldwide Lab-Based Immunoassay Sales by Analyte Type 2005-2010
• Table 7-3 Revenue History of Leading Immunoassay Vendors 2003-2005
• Table 7-4 Selected Proteomics and Protein Pattern Products
• Table 7-5 Selected New Commercial Tumor Markers, 2002-2005
• Table 7-6 Traditional and New Tumor Markers
• Table 7-7 Selected Immunoassay Innovations, 2005

Chapter Eight: Molecular Assays

• Table 8-1 Worldwide Molecular Test Sales by Type 2005-2010
• Table 8-2 Molecular Test Revenues of Top 14 IVD Vendors, 2003-2005
• Table 8-3 Molecular Test Sales for Infectious Diseases by Test Type (HIV, Hepatitis, Gonorrhea/Chlamydia, Organism ID & Antibiotic Resistance, Mycobacteria, Respiratory, West Nile, Others) 2005-2010
• Table 8-4 Selected Infectious Disease Molecular Test Innovations, 2005
• Table 8-5 Worldwide Molecular Test Sales for SNP Testing by Type (Thrombophilia, Cystic Fibrosis, Hemochromatosis, Other) 2005-2010
• Table 8-6 Most Frequently Requested Genetic Tests
• Table 8-7 Selected SNP Test Innovations 2005
• Table 8-8 Major Molecular Tests Platforms and Their Manufacturers
• Table 8-9 Selected Molecular Assay Innovations, 2005
• Table 8-10 Selected PGx Products, 2005

Chapter Nine: Hematology

• Table 9-1 Revenue History of the Five Major Hematology Vendors 2003-2005

Chapter Ten: Coagulation

• Table 10-1 Worldwide Coagulation Sales by Segment 2005-2010
• Table 10-2 Top 5 Coagulation Company Revenues 2003

Chapter Eleven: Microbiology and Virology

• Table 11-1 Worldwide Microbiology/Virology Sales by Type 2005-2010
• Table 11-2 Selected Microbiology/Virology Innovations, 2002-2005
• Table 11-3 Selected Biowarfare Agent Tests
• Table 11-4 Selected SARS Tests on the Market, 2002-2004

Chapter Twelve: Blood Banking Services

• Table 12-1 Selected Blood Bank Product Innovations

Chapter Thirteen: Histology and Cytology

• Table 13-1 Worldwide Histology/Cytology Sales by Test (Pap, ISH, IHC, Traditional [non-Pap], HPV, HER-2) or Type (Flow Cytometry, Tissue Microarrays) 2005-2010
• Table 13-2 Revenues of the Four Major Automated Histology Companies 2003-2005
• Table 13-3 Selected IHC and ISH Reagent Companies
• Table 13-4 Selected Histology/Cytology Innovations, 2005
• Table 13-5 Selected Circulating Tumor Cell Products
• Table 13-6 Selected PGx Products, 2003-2005
• Table 13-7 Revenue History of Flow Cytometry by Company, 2003-2005
• Table 13-8 Selected Flow Cytometry Innovations, 2002-2005